MedFemTech Congress will connect and engage key players in the female medical technology sector, launching a global community of medical professionals, tech visionaries, innovators, investors and other experts from across the health care ecosystem – representing doctors, hospitals, clinics, academia, venture capital firms and technology solution companies. The overall fem-tech market was valued at $18.7B in 2019 and is projected to reach $60.1B by 2027, with a CAGR of over 15.6%. The industry value remains underestimated. Over 1,500 companies have been classified as med-fem-tech, categorized into 14 subsectors and 8 aggregated subsectors by application. Of the total market, pregnancy is the largest one. The inaugural congress will offer a 2-day scientific program focusing on the main medical challenges facing women, primarily highlighting the following topics: Maternal health, prenatal care and breastfeeding Menstrual health Pelvic, sexual organ and other gynecological cancers Reproductive health, assisted reproduction technologies Endometriosis, pelvic floor and sexual health Women’s cancer: breast cancer and reconstruction, ovarian cancer and cervical cancer Menopause and peri- and post-menopausal symptoms Contraception: oral contraceptives and IUDs Gynecological infections: bacterial vaginosis, HPV and sexually transmitted diseases Longevity Diagnostics Artificial intelligence (AI) for women’s health Advanced medicine for women Each topic will be headlined by a medical presentation and followed by 5-10 brief “lightning talks” by start-ups focusing on their relevant innovation
-
Secteur
-
Santé et services sociaux
-
Taille de l’entreprise
-
2-10 employés
-
Siège social
-
Paris
-
Type
-
Société civile/Société commerciale/Autres types de sociétés
-
Fondée en
-
2023
-
Domaines
-
Women's Health, Menstrual health, Pelvic, sexual organ and other gynecological cancers, Reproductive health, assisted reproduction technologies, MedFem, Pelvic floor and sexual health, Endometriosis, ovarian cancer, Cervical cancer, breast cancer, Menopause, Contraception, Gynecological infections, Artificial intelligence (AI) for women’s health, Maternal health, prenatal care, breastfeeding et Start up